Boston Trust Walden’s Helen of Troy HELE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-139,981
Closed -$15.5M 369
2022
Q4
$15.5M Sell
139,981
-3,773
-3% -$367K 0.14% 183
2022
Q3
$13.9M Buy
143,754
+4,223
+3% +$543K 0.14% 186
2022
Q2
$22.7M Buy
139,531
+2,023
+1% +$381K 0.21% 157
2022
Q1
$26.9M Buy
137,508
+2,148
+2% +$453K 0.22% 154
2021
Q4
$33.1M Sell
135,360
-16
-0% -$3.79K 0.27% 132
2021
Q3
$30.4M Buy
135,376
+2,656
+2% +$608K 0.27% 136
2021
Q2
$30.3M Buy
+132,720
New +$29.2M 0.27% 135

Other funds holding HELE

Boston Trust Walden's HELE Position: Q1 2023 in Review

Boston Trust Walden sold out of Helen of Troy (HELE) in Q1 2023, closing a stake of 139,981 shares — an estimated $15.5M sold.

Boston Trust Walden first reported a position in HELE in Q2 2021 and held it in 7 quarters. The position peaked at $33.1M in Q4 2021. 248 funds tracked by Wall St. Rank hold HELE as of Q1 2023.

  • Boston Trust Walden reported no remaining Helen of Troy position as of Q1 2023 after selling out during the quarter.
  • Boston Trust Walden sold 139,981 Helen of Troy shares in Q1 2023, an estimated $15.5M.
  • Boston Trust Walden first reported a position in Helen of Troy in Q2 2021 and held it in 7 quarters.
  • Boston Trust Walden's Helen of Troy position peaked at $33.1M in Q4 2021.
  • 248 funds tracked by Wall St. Rank held Helen of Troy as of Q1 2023.

Based on Boston Trust Walden's 13F filing for Q1 2023, filed 19 Apr 2023.